Table 1 Baseline, clinical and Socio-demographic characteristics of the recruited Parkinson’s disease patients (n = 114)
Characteristics | Value |
|---|---|
Age (yr) | |
Mean (SD) | 61.3 (11.0) |
Gender NO. (%) | |
Female | 25 (21.9) |
Male | 89 (78.1) |
Level of Education NO. (%) | |
Illiterate | 4 (3.5) |
Primary and/or Secondary | 32 (28.3) |
High School/Diploma | 34 (30.1) |
College and/or University | 43 (38.1) |
Duration of Disease (yr) | |
Mean (SD) | 6.3 (5.1) |
Co-morbidities NO. (%) | |
Depression | 25 (22.3) |
Cardiovascular Disease | 19 (17.1) |
Hypertension | 18 (16.1) |
Diabetes | 15 (13.5) |
Osteoarthritis | 10 (9.0) |
UPDRS Score | |
Mean (SD) | 1.8 (2.0) |
Part I-mental | 11.3 (7.7) |
Part II-ADL | 14.7 (9.6) |
Part III-motor | 3.4 (2.8) |
Part IV-complications | 31.3 (18.1) |
Total | |
Hoehn & Yahr Stage | |
Mean (SD) | 1.9 (0.9) |
Schwab and England activities of daily living score (%) | |
Mean (SD) | 81.7 (17.7) |
Daily levodopa dose (mg) | |
Mean (SD) | 850 (495) |
Duration of levodopa administration (yr) | |
Mean (SD) | 4.6 (4.5) |